USPTO Director Jon Dudas and IP Professionals Discuss New USPTO Continuations and Claims Rules and Their Practical Implications
12 September 2007
The Patent Nation Conference series features complimentary programs for in-house counsel and business executives to exchange insights on the evolving patent landscape. The United States Patent and Trademark Office (USPTO) has just officially published its new claims and continuations rules, which are aimed at improving patent quality and efficiency. During this session, participants heard the background and implications of the new rules from Jon W. Dudas – Under Secretary of Commerce for Intellectual Property, and Director of the USPTO – along with leading practitioners in the field.
Additionally, a panel discussion will focus on:
- A checklist of steps to take during the 60-day window before the final rules are effective
- Scenarios that would justify extra continuations under the final rules
- The number of continuations filed as a matter of right
- The “bonus” continuation for transition cases as well as the definition of a “transition” case
- The importance of “serial divisionals” particularly applicable to companies within the biotechnology, pharmaceutical, and nanotechnology industries
Moderator
- Philip G. Kiko, Of Counsel, Government & Public Affairs Practice
Guest Speakers
- Jon W. Dudas, Under Secretary of Commerce for Intellectual Property and Director, USPTO
- Robert Bahr, Senior Patent Counsel, Office of the Deputy Commissioner for Patent Examination Policy, USPTO
Foley Panelists
- Courtenay C. Brinckerhoff, Partner, Biotechnology & Pharmaceutical Practice
- Stephen P. Fox, Former Vice President and Deputy General Counsel for Intellectual Property, Hewlett-Packard Company
- Stephen B. Maebius, Partner and Co-Chair, Life Sciences Industry Team
People
Related Insights
07 February 2025
Health Care Law Today
The Colorado AI Act: Implications for Health Care Providers
Artificial intelligence (AI) is increasingly being integrated into health care operations, from administrative functions such as scheduling and billing to clinical decision-making, including diagnosis and treatment recommendations. Although AI offers significant benefits, concerns regarding bias, transparency, and accountability have prompted regulatory responses.
07 February 2025
Trump Tariffs 2.0: FAQs on How Your Contract Comes into Play
Video FAQ: Does your contract protect you? The Trump administration’s tariffs have reshaped global trade—but how do they impact your contracts? From force majeure to price adjustment clauses, understanding these provisions is critical for protecting your business.
05 February 2025
Manufacturing Industry Advisor
Foley Automotive Update
Foley is here to help you through all aspects of rethinking your long-term business strategies, investments, partnerships, and technology. Contact the authors, your Foley relationship partner, or our Automotive Team to discuss and learn more.